Serial Number
97401213
Owner
Hyloris Pharmaceuticals SAAttorney
Clifford D. HyraFiling Date
May 9, 2022
HYLORIS Trademark
Serial Number: 97401213 • Registration: 7656999
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Clifford D Hyra FRESH IP PLC
11710 PLAZA AMERICA DRIVE SUITE 2000
RESTON, VA 20190
United States
Trademark Details
Filing Date
May 9, 2022
Registration Date
January 21, 2025
Published for Opposition
December 3, 2024
Goods & Services
Custom manufacture of cardiovascular pharmaceuticals and medicines for treatment of cardiovascular diseases by pharmaceutical compounders; providing technical information in the field of pharmaceutical manufacturing of cardiovascular pharmaceuticals; biomanufacturing for others, namely, manufacturing of cardiovascular pharmaceuticals using biological organisms in the manufacturing process
Cardiovascular pharmaceuticals; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of cardiovascular and cardiopulmonary diseases and disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; none of the aforementioned for the treatment of non-cardiological inflammatory disorders
Pharmaceutical research and development services in the field of cardiovascular and cardiopulmonary disease and disorders; Development of cardiovascular pharmaceutical preparations and medicines for the treatment of cardiovascular diseases; cardiovascular pharmaceutical products development; Laboratory research services in the field of pharmaceuticals and new products, namely, cardiovascular pharmaceutical and biotechnological products in the nature of cardiovascular pharmaceuticals; conducting early evaluations in the field of new cardiovascular pharmaceuticals; testing, inspection and research of cardiovascular pharmaceuticals; research and development in the biotechnology fields in relation to cardiovascular and cardiopulmonary diseases and disorders; technical consulting services in the fields of pharmaceutical research and development, biotechnology; technical consulting services in the field of scientific laboratory services, namely, laboratory testing, diagnostics; all the aforementioned in relation to cardio vascular and cardiopulmonary diseases and disorders
